Nalaganje...
Ticagrelor Associated Heart Block: The Need for Close and Continued Monitoring
Ticagrelor is an antiplatelet agent prescribed to prevent the development of adverse cardiac events after acute coronary syndrome (ACS). According to the PLATO trial, ticagrelor is associated with ventricular pauses in the first week of treatment; however, these episodes were felt to be asymptomatic...
Shranjeno v:
| izdano v: | Case Rep Cardiol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Publishing Corporation
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299195/ https://ncbi.nlm.nih.gov/pubmed/28246559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5074891 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|